# 2025-19348: DEA Targets New Synthetic Drug for Schedule I Ban

2025-19348, Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I, is a Federal Register proposed rule from Justice Department, Drug Enforcement Administration published 2025-10-02 (as of 2026-06-11).

- Canonical: https://policyrisk.com/federal-register/2025-19348
- As of: 2026-06-11
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-19348
- Title: Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I
- Type: Proposed Rule
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 47663
- Published: 2025-10-02
- Effective: unknown
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-11

## In one line

DEA Targets New Synthetic Drug for Schedule I Ban

## Summary

The DEA wants to officially put MDMB-4en-PINACA, a powerful drug, into Schedule I, meaning it’s illegal to make, sell, or use. This move helps the U.S. follow international drug rules and keeps strict penalties for anyone caught handling it. If approved, these rules will stay in place permanently, affecting manufacturers, researchers, and users right away.

## Abstract

The Drug Enforcement Administration proposes placing methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate (other name: MDMB-4en-PINACA), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act. This action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. If finalized, this action would make permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle MDMB-4en-PINACA.

## Effects PRIA read

- Possession and Handling Made Illegal: cost, high. If finalized, MDMB-4en-PINACA would be placed in Schedule I. That would make it illegal to manufacture, distribute, import, export, or possess MDMB-4en-PINACA, and the existing Schedule I regulatory controls plus civil, administrative, and criminal sanctions would apply to people who handle it.
- Researchers Subject to Schedule I Controls: cost, high. If finalized, people who 'engage in research, conduct instructional activities or chemical analysis' with MDMB-4en-PINACA would be covered by the same Schedule I regulatory controls and civil, administrative, and criminal sanctions as other Schedule I substances.
- Manufacturers and Traders Face Permanent Controls: cost, high. If finalized, MDMB-4en-PINACA would be placed in Schedule I and the rule would make permanent the existing regulatory controls and civil, administrative, and criminal sanctions that apply to manufacture, distribution, importation, and export of Schedule I substances.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-19348 on federalregister.gov](https://www.federalregister.gov/documents/2025/10/02/2025-19348/schedules-of-controlled-substances-placement-of-mdmb-4en-pinaca-in-schedule-i)
- [2025-19348 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-10-02/pdf/2025-19348.pdf)

## Related
- [Previous: 2025-19280, Visibility Protection: Regional Haze State Plan Requirements Rule Revision](https://policyrisk.com/federal-register/2025-19280)
- [Next: 2025-19363, Fishery Management Plans of St. Croix and St. Thomas and St. John; Queen Trigge…](https://policyrisk.com/federal-register/2025-19363)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-19348 (as of 2026-06-11).
